Repositioning of the global epicentre of non-optimal cholesterol. | Department of Endocrinology, Diabetes & Metabolism
Order Books Courses Offered
+91 416 228 2528
CMC Logo
Department of Endocrinology, Diabetes & Metabolism
Christian Medical College Vellore
Department of Endocrinology Christian Medical College Vellore
Book
Appointment
Patient
Services
Admissions
Site Map Order Books
Department of Endocrinology, Diabetes & Metabolism
Christian Medical College Vellore
Not to be ministered unto but to minister
News

The Department of Endocrinology, Christian Medical College Vellore has launched its official Endocrinology CMC Vellore Android app now available on the Google Play Store — users can download it to access the latest department updates, academic resources, event notifications, and educational materials on diabetes and endocrine care.

Repositioning of the global epicentre of non-optimal cholesterol.

Nature Vol. 582 · Issue 7810 · pp. 73-77

PMID 32494083 DOI 10.1038/s41586-020-2338-1

Cite This Article

NCD Risk Factor Collaboration (incl. Thomas N). Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582(7810):73-77. doi:10.1038/s41586-020-2338-1

Abstract

High blood cholesterol is typically considered a feature of wealthy western countries. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol-which is a marker of cardiovascular risk-changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million-4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged
  • 80 and over
  • Bayes Theorem
  • Cholesterol
  • HDL
  • Cholesterol
  • LDL
  • Female
  • Humans
  • Hypercholesterolemia
  • Internationality
  • Male
  • Middle Aged
  • Myocardial Ischemia
  • Stroke
  • Triglycerides
  • Young Adult
MAKE AN APPOINTMENT
CMC Endocrinology
Add to your Home Screen for quick access

Tap the Share button in your browser

then select "Add to Home Screen"

CMC Endocrinology

CMC Endocrinology

CMC Vellore

🔔 Notifications

← Back to notifications